24-hour Serial Spirometric Assessment of Once-Daily Fluticasone furoate/Umeclidinium/Vilanterol Versus Twice-Daily Budesonide/Formoterol in Patients with COPD: Analysis of the FULFIL Study
figureposted on 28.09.2020, 10:22 by David A Lipson, Ruby Birk, Noushin Brealey, Chang-Qing Zhu
The above Summary Slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).